Posts

Showing posts from June, 2023

If you need pdf note please contact me over messenger.

 


How can you get the best responses to anti-viral drug treatment?

T o optimize the responses to antiviral drug treatment, several factors should be considered. Here are some key strategies: 1. Early treatment: Initiating antiviral therapy as early as possible after the onset of symptoms or diagnosis is crucial. Viral replication and spread can be more effectively controlled when antiviral drugs are administered early in the course of the infection. 2. Adherence to treatment regimen: It is essential to adhere to the prescribed dosing schedule and complete the full course of antiviral treatment. Skipping doses or stopping treatment prematurely can lead to inadequate drug levels and reduced effectiveness. Follow the instructions provided by the healthcare provider or pharmacist closely. 3. Proper drug selection: Different antiviral drugs target specific viruses or classes of viruses. Ensuring that the chosen antiviral medication is effective against the specific virus causing the infection is crucial. Consultation with healthcare professionals,

As a pharmacist, how can you interpret a drug which is bound to the plasma proteins almost 90%?

As a pharmacist, understanding the extent to which a drug is bound to plasma proteins is important for evaluating its pharmacokinetic properties and potential drug interactions. When a drug is bound to plasma proteins, it is typically not available for therapeutic action or distribution to tissues. Here's how you can interpret a drug that is bound to plasma proteins to a high degree, such as 90%: 1.      Bioavailability: The degree of protein binding can affect the bioavailability of a drug, which refers to the fraction of the administered dose that reaches systemic circulation. If a drug is highly bound to plasma proteins, it may have a lower free fraction available for distribution, potentially reducing its bioavailability. 2.      Distribution: Protein-bound drugs are usually unable to cross cell membranes easily. Consequently, a drug with a high plasma protein binding may have limited distribution to tissues, leading to a more confined therapeutic effect or reduced penetrat

How a dogs product shifts to a star product

The BCG matrix is a business planning tool that helps you evaluate the strategic position of a firm’s products or services in terms of their market share and market growth. The matrix divides products or services into four categories: stars, cash cows, question marks and dogs. Given below that’s why it shifting dogs product to star product: (1)          Identify the current market share and market growth of the pharma dogs product and the star product. (2)          Assess the potential benefits and costs of shifting resources from the pharma dogs product to the star product. (3)          Compare the expected return on investment (ROI) of the two products after the shift. (4)          Decide whether the shift is worth pursuing or not.

Make a SWOT analysis of the following BRAND products: a. Comet (500mg)" b. Eromycin (250mg)

  (a) Comet is a brand name of Metformin Hydrochloride, an oral antidiabetic drug that belongs to the biguanide class. It is used to treat type 2 diabetes by reducing blood glucose levels and improving insulin sensitivity. It is manufactured by Square Pharmaceuticals, a leading pharmaceutical company in Bangladesh. To make a SWOT analysis of Comet 500 mg, you need to identify its strengths, weaknesses, opportunities and threats in the market. Here are some possible examples: Strengths: - Comet is a well-established and widely prescribed brand of metformin in Bangladesh. - Comet has a proven efficacy and safety profile for the treatment of type 2 diabetes. - Comet is available in both immediate-release and extended-release formulations, offering flexibility and convenience to patients. - Comet is affordable and accessible to a large segment of diabetic patients in Bangladesh. Weaknesses: - Comet faces intense competition from other brands of metformin and other clas

Hospital management

What is the difference between Loss on drying(LOD) and moisture content (MC)?

Given below are the differences between Loss on Drying (LOD) and Moisture Content (MC) in the context of pharmacy: Aspect Loss on Drying (LOD) Moisture Content (MC) Definition The measurement of the weight loss of a substance upon drying The measurement of the water content within a substance Purpose Determines the volatile matter in a sample Quantifies the total water content in a sample Method Involves heating the sample to evaporate moisture Utilizes a variety of techniques to assess water content Measurement Reported as a percentage of the initial sample weight Reported as a percentage or absolute value of the sample weight Applicability Primarily used for substances that are prone to volatilize on drying Applicable to a wide range of substances, including liquids, solids, and s

BOOK

Translate

আপনিও লিখুন

Name

Email *

Message *



animated-world-globe-image-0029Total view web counter

পড়াশোনাতে আপনাকে স্বাগতম
ডাউনোড করুন আমাদের Mobile app;